Korro Bio, Inc.
KRRO
$20.25
$0.1750.87%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -25.77M | -23.39M | -21.20M | -21.00M | -21.83M |
| Total Depreciation and Amortization | 1.23M | 1.23M | 1.25M | 865.00K | 721.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.17M | 1.58M | 1.27M | 1.10M | 1.91M |
| Change in Net Operating Assets | 3.15M | -3.87M | 11.18M | 2.94M | 4.61M |
| Cash from Operations | -19.23M | -24.45M | -7.50M | -16.10M | -14.59M |
| Capital Expenditure | -140.00K | -119.00K | -1.45M | -4.88M | -5.96M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -11.16M | 32.90M | -1.31M | -7.70M | -96.43M |
| Cash from Investing | -11.30M | 32.78M | -2.77M | -12.58M | -102.39M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 5.00K | 172.00K | 932.00K | 728.00K | 67.56M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 5.00K | 172.00K | 932.00K | 728.00K | 67.56M |
| Foreign Exchange rate Adjustments | -9.00K | -- | -6.00K | 2.00K | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | 2.00K | -2.00K | -- |
| Net Change in Cash | -30.53M | 8.50M | -9.33M | -27.95M | -49.43M |